Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.

Clinical trial NCT05168215 · UNKNOWN

Trial details

NCT number: NCT05168215
Sponsor: Elpen Pharmaceutical Co. Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Scleroderma Digital Ulcer Autoimmune Diseases Diffuse Cutaneous Systemic Sclerosis Reynold Syndrome

Start date: 2022-01-01
Primary completion: 2024-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.